According to Immuno-Biological Laboratories latest financial reports the total liabilities of 4570 is $2.50M, an increase of 5.56% to 2022. At the end of 2022 company had $2.37M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that Immuno-Biological Laboratories is responsible for during its operational activities.
Year | Total liabilities | Change |
---|---|---|
2023 | $2.50M | 5.56% |
2022 | $2.37M | 61.43% |
2021 | $1.47M | -50.83% |
2020 | $2.99M | -47.01% |
2019 | $5.63M | - |